GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 887 filers reported holding GLAXOSMITHKLINE PLC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $634,000 | +62.1% | 16,598 | +51.6% | 0.06% | +100.0% |
| Q1 2021 | $391,000 | -60.5% | 10,945 | -59.3% | 0.03% | -73.8% |
| Q4 2020 | $989,000 | -23.2% | 26,867 | -21.5% | 0.11% | -51.6% |
| Q3 2020 | $1,288,000 | +85.6% | 34,211 | +131.5% | 0.22% | +229.9% |
| Q4 2019 | $694,000 | +207.1% | 14,781 | +161.8% | 0.07% | +415.4% |
| Q2 2019 | $226,000 | -59.6% | 5,645 | -57.8% | 0.01% | -59.4% |
| Q1 2019 | $559,000 | -9.3% | 13,383 | -17.0% | 0.03% | -3.0% |
| Q4 2018 | $616,000 | -41.6% | 16,123 | -38.5% | 0.03% | -49.2% |
| Q3 2018 | $1,054,000 | -28.5% | 26,230 | -28.3% | 0.06% | 0.0% |
| Q2 2018 | $1,474,000 | +127.5% | 36,572 | +120.3% | 0.06% | +85.7% |
| Q1 2018 | $648,000 | -85.7% | 16,598 | -87.0% | 0.04% | -85.4% |
| Q4 2017 | $4,517,000 | +1830.3% | 127,337 | +2190.2% | 0.24% | +895.8% |
| Q1 2017 | $234,000 | +15.3% | 5,560 | +10.6% | 0.02% | -17.2% |
| Q4 2015 | $203,000 | -95.1% | 5,025 | -93.9% | 0.03% | -92.6% |
| Q2 2013 | $4,110,000 | – | 82,251 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |